Abpro Holdings, Inc. (ABP)
NASDAQ: ABP · Real-Time Price · USD
4.040
-0.020 (-0.49%)
At close: Jan 9, 2026, 4:00 PM EST
4.110
+0.070 (1.73%)
After-hours: Jan 9, 2026, 6:01 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Antibodies
183.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
183.00K